EKF to distribute FDA-cleared Lucica glycated albumin test

Create PDF

July 2022—EKF Diagnostics announced the availability of the FDA-cleared Lucica Glycated Albumin-L test kit, manufactured by Asahi Kasei Pharma Corp. and sold exclusively in the United States by EKF.

Lucica Glycated Albumin-L is a specific, quantitative test for glycated albumin for the intermediate-term monitoring of glycemic control in patients with diabetes. It is an enzymatic method for use on compatible clinical chemistry analyzers that have open channel capability. Glycated albumin and total albumin are determined in separate reactions and results are expressed as a ratio (percent). The test is also standardized to an established reference material.